Trial Profile
A Pilot, Open, Monocenter, Randomized Two Parallel Groups, Clinical Efficacy Trial: Comparison Continuous Versus on Demand Regimen of Treatment With Levocetirizine 5 mg Oral Tablets, Once a Day, in Adults Suffering From Persistent Allergic Rhinitis (PER) Over 6 Months
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2019
Price :
$35
*
At a glance
- Drugs Levocetirizine (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- Acronyms ATAREAL
- Sponsors UCB Pharma Inc
- 10 Jul 2007 Status changed from in progress to completed
- 29 Aug 2006 Status change
- 27 Nov 2005 New trial record.